2014
DOI: 10.1371/journal.pone.0093996
|View full text |Cite
|
Sign up to set email alerts
|

Synergistic Effects of Targeted PI3K Signaling Inhibition and Chemotherapy in Liposarcoma

Abstract: While liposarcoma is the second most common soft tissue malignant tumor, the molecular pathogenesis in this malignancy is poorly understood. Our goal was therefore to expand the understanding of molecular mechanisms that drive liposarcoma and identify therapeutically-susceptible genetic alterations. We studied a cohort of high-grade liposarcomas and benign lipomas across multiple disease sites, as well as two liposarcoma cell lines, using multiplexed mutational analysis. Nucleic acids extracted from diagnostic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 33 publications
0
13
0
Order By: Relevance
“…Overall, previously published results indicate a fundamental relevance of PI3K/Akt signals with respect to the specific liability of MLS tumor cells, accomplished either by genetic PIK3CA and/or PTEN alterations or complex signaling networks (8,12,(15)(16)(17)22) resulting in aberrant activation of PI3K activity. This preclinical study was conducted to explore the functional importance of PI3K/ Akt signals in MLS tumorigenesis, and to establish a molecularly targeted strategy employing small-molecule PI3K inhibitors.…”
Section: Introductionmentioning
confidence: 58%
“…Overall, previously published results indicate a fundamental relevance of PI3K/Akt signals with respect to the specific liability of MLS tumor cells, accomplished either by genetic PIK3CA and/or PTEN alterations or complex signaling networks (8,12,(15)(16)(17)22) resulting in aberrant activation of PI3K activity. This preclinical study was conducted to explore the functional importance of PI3K/ Akt signals in MLS tumorigenesis, and to establish a molecularly targeted strategy employing small-molecule PI3K inhibitors.…”
Section: Introductionmentioning
confidence: 58%
“…Moreover, AKT inactivation might lead to an increase in the anti-proliferative effect of the cell cycle inhibitor p21 that is normally held by AKT in the cytoplasm [29]. In general, the PI3K/AKT survival pathway is crucial for the survival of many soft tissue tumor subtypes [11,31,32].…”
Section: Discussionmentioning
confidence: 99%
“…MLS have an oncogenic activation of the PI3K pathway through mutations in the PIK3CA gene [32]. Only 10-15% of the MLS have this mutation and none of MLS402-91 or MLS1754-92 have these mutations [26].…”
Section: Discussionmentioning
confidence: 99%
“…This latter statement is supported by the increased cytotoxicity observed in tumor cells of different origins to chemotherapy agents such as microtubule-targeting drugs (paclitaxel, docetaxel and vinblastine) [115], topotecan [116], cisplatin [117], and doxorubicin [118], when treatment was combined with inhibitors of components of PI3K/Akt pathway. Likewise, early evidence of antitumor activity, induced by either inhibiting Akt using MK-2206 [119] plus carboplatin and paclitaxel, docetaxel, or erlotinib, or inhibiting PI3K using the pan-class 1A PI3K inhibitor BKM120 [120] plus carboplatin and paclitaxel in patients with different solid tumors, supports the above-described role for PI3K/Akt in resistance to chemotherapy agents [119,120].…”
Section: Importance Of Akt In Radiotherapy Resistancementioning
confidence: 95%